SERPINA3 and breast cancer: Specifically, Tamoxifen upregulated SERPINA3 and IGLV7-43, while Anastrozole-treated T47Ds downregulated IGCL3 (Supplementary Table 2) which is indicated by the Human Protein Atlas as being associated with favourable outcome in breast cancer.